Oryzon Genomics Dividend

Dividend criteria checks 0/6

Oryzon Genomics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

0.9%

Buyback Yield

Total Shareholder Yield0.9%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend updates

No updates

Recent updates

Growth Investors: Industry Analysts Just Upgraded Their Oryzon Genomics S.A. (BME:ORY) Revenue Forecasts By 54%

Oct 03
Growth Investors: Industry Analysts Just Upgraded Their Oryzon Genomics S.A. (BME:ORY) Revenue Forecasts By 54%

Oryzon Genomics S.A. (BME:ORY) Screens Well But There Might Be A Catch

Jun 09
Oryzon Genomics S.A. (BME:ORY) Screens Well But There Might Be A Catch

Is Oryzon Genomics (BME:ORY) Using Too Much Debt?

Apr 04
Is Oryzon Genomics (BME:ORY) Using Too Much Debt?

Industry Analysts Just Made A Dazzling Upgrade To Their Oryzon Genomics S.A. (BME:ORY) Revenue Forecasts

Jul 24
Industry Analysts Just Made A Dazzling Upgrade To Their Oryzon Genomics S.A. (BME:ORY) Revenue Forecasts

Is Oryzon Genomics (BME:ORY) Weighed On By Its Debt Load?

May 01
Is Oryzon Genomics (BME:ORY) Weighed On By Its Debt Load?

Oryzon Genomics (BME:ORY) Has Debt But No Earnings; Should You Worry?

Feb 26
Oryzon Genomics (BME:ORY) Has Debt But No Earnings; Should You Worry?

If You Had Bought Oryzon Genomics (BME:ORY) Shares A Year Ago You'd Have Earned 18% Returns

Jan 04
If You Had Bought Oryzon Genomics (BME:ORY) Shares A Year Ago You'd Have Earned 18% Returns

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if ORY's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ORY's dividend payments have been increasing.


Dividend Yield vs Market

Oryzon Genomics Dividend Yield vs Market
How does ORY dividend yield compare to the market?
SegmentDividend Yield
Company (ORY)n/a
Market Bottom 25% (ES)2.3%
Market Top 25% (ES)5.2%
Industry Average (Biotechs)1.5%
Analyst forecast (ORY) (up to 3 years)n/a

Notable Dividend: Unable to evaluate ORY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ORY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate ORY's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ORY has not reported any payouts.


Discover strong dividend paying companies